Pages that link to "Q46481453"
Jump to navigation
Jump to search
The following pages link to Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes (Q46481453):
Displaying 50 items.
- Controversies in stable coronary artery disease (Q28194400) (← links)
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome (Q29619211) (← links)
- Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension (Q30434226) (← links)
- Adiponectin is associated with cardiovascular disease in male renal transplant recipients: baseline results from the LANDMARK 2 study (Q33509887) (← links)
- The role of novel biomarkers of cardiovascular disease in chronic kidney disease: focus on adiponectin and leptin (Q33572275) (← links)
- Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment (Q33776230) (← links)
- Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs (Q33821236) (← links)
- Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients (Q34177113) (← links)
- Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction (Q34231611) (← links)
- Adiposopathy is a more rational treatment target for metabolic disease than obesity alone (Q34498578) (← links)
- A pilot study of ezetimibe vs. atorvastatin for improving peripheral microvascular endothelial function in stable patients with type 2 diabetes mellitus (Q35562323) (← links)
- Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy (Q35673446) (← links)
- Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome (Q36148478) (← links)
- Treatment of multiple-risk patients: using combination therapy to treat beyond LDL lowering (Q36214881) (← links)
- Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects (Q36271369) (← links)
- Effects of simvastatin on serum adiponectin: a meta-analysis of randomized controlled trials (Q36306780) (← links)
- Protecting the endothelium: a new focus for management of chronic kidney disease (Q36379593) (← links)
- Differential metabolic actions of specific statins: clinical and therapeutic considerations (Q36406951) (← links)
- Paradoxical Hyperadiponectinemia is Associated With the Metabolically Healthy Obese (MHO) Phenotype in African Americans (Q36501887) (← links)
- Reduction of C-reactive protein and the use of anti-hypertensives. (Q36596821) (← links)
- Rosuvastatin does not affect fasting glucose, insulin resistance, or adiponectin in patients with mild to moderate hypertension (Q36837587) (← links)
- Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. (Q36892489) (← links)
- The impact of insulin resistance on endothelial function, progenitor cells and repair (Q36892494) (← links)
- Are statins effective for simultaneously treating dyslipidemias and hypertension? (Q36896062) (← links)
- Endothelial function, arterial stiffness and lipid lowering drugs (Q36936335) (← links)
- An integrated view of insulin resistance and endothelial dysfunction (Q37035654) (← links)
- Targeting converging therapeutic pathways to overcome hypertension (Q37176969) (← links)
- Evaluation of adverse effects of lisinopril and rosuvastatin on hematological and biochemical analytes in wistar rats (Q37198943) (← links)
- Treatment of spontaneously hypertensive rats with rosiglitazone ameliorates cardiovascular pathophysiology via antioxidant mechanisms in the vasculature (Q37337305) (← links)
- Does reversal of oxidative stress and inflammation provide vascular protection? (Q37355471) (← links)
- Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients. (Q37362218) (← links)
- The importance of considering alternative or combination strategies for lowering LDL-C. (Q37378335) (← links)
- The effect of telmisartan on endothelial function and arterial stiffness in patients with essential hypertension (Q37408666) (← links)
- Current pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabetics (Q37645663) (← links)
- Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus (Q37831911) (← links)
- Effect of Angiotensin-converting enzyme inhibitors and Angiotensin receptor antagonists in atherosclerosis prevention (Q38007893) (← links)
- The antihypertensive actions of statins: modulation by salt intake (Q38029526) (← links)
- Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin. (Q38313076) (← links)
- MKR mice are resistant to the metabolic actions of both insulin and adiponectin: discordance between insulin resistance and adiponectin responsiveness. (Q38315377) (← links)
- The role of adiponectin in atherosclerosis: do lipids tip the scales? (Q40377147) (← links)
- Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events (Q41190859) (← links)
- Angiotensin converting enzyme inhibitors remain the first treatment of choice (Q42617282) (← links)
- Diabetic and nondiabetic patients express similar adipose tissue adiponectin and leptin levels (Q43152301) (← links)
- Lipid and C-reactive protein levels, cardiovascular disease risk factors and simvastatin treatment in Brazilian individuals. (Q43190405) (← links)
- Epicardial adipose tissue expression of adiponectin is lower in patients with hypertension. (Q43548500) (← links)
- Effects of ramipril and simvastatin on the oxidative stress of diabetic rats (Q46198509) (← links)
- Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes. (Q46482440) (← links)
- Atorvastatin administration after percutaneous coronary intervention in patients with coronary artery disease and normal lipid profiles: impact on plasma adiponectin level. (Q46548622) (← links)
- High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance (Q46673641) (← links)
- Beneficial effects of ramipril on myocardial diastolic function in patients with type 2 diabetes mellitus, normal LV systolic function and without coronary artery disease: a prospective study using tissue Doppler (Q46833695) (← links)